Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pseudomyxoma Peritonei, Appendix Mucinous

Dario Baratti

MD

🏢Fondazione IRCCS Istituto Nazionale dei Tumori di Milano🌐Italy

Surgeon, Peritoneal Surface Malignancy Unit

33
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dario Baratti is a surgical oncologist who has contributed extensively to the clinical management of pseudomyxoma peritonei (PMP), publishing outcomes from one of Europe's largest CRS-HIPEC series for PMP. He has helped validate the PSOGI (Peritoneal Surface Oncology Group International) consensus classification of PMP into low-grade mucinous carcinoma peritonei, high-grade mucinous carcinoma peritonei, and signet ring cell variants, each with distinct prognosis after CRS-HIPEC. He has also studied systemic chemotherapy regimens for recurrent or unresectable PMP.

Share:

🧪Research Fields 研究领域

pseudomyxoma peritonei CRS-HIPEC outcomes
appendix mucinous adenocarcinoma systemic therapy
PSOGI PMP classification
PMP long-term survival after CRS
mucinous appendix cancer biology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Dario Baratti 的研究动态

Follow Dario Baratti's research updates

留下邮箱,当我们发布与 Dario Baratti(Fondazione IRCCS Istituto Nazionale dei Tumori di Milano)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment